Registration
WILLIAMS AND JENSEN, PLLC for DR. EMIL KAKKIS
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA drug approval process for rare diseases, including increased use of biomarkers in the Accelerated Approval Pathway, clinical trial design and other barriers to approval.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
| SUSAN HIRSCHMANN New | — |
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
| KURT SCHRADER New | Former Member of Congress |
| LAURA M SIMMONS New | Advisor, Office of Legislative Affairs, Dept of Homeland Security |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.